Merck

Merck Postpones Dutch Closures

Merck KGaA Profit After Tax Jumps 70% to €187 Million in Q2 2010

Merck Gets EU Nod for U.S. Biotech Millipore Buy

Time For Action

Germany Cuts Drug Industry's Pricing Power

Nanotech Robots Deliver Gene Therapy Through Blood

'A Merger For Growth'

Is Merck KGaA's $6 Billion Bid for Millipore Too Costly?

Update: Merck KGaA Buys Millipore to Stabilize Business

Germany's Merck to Buy Millipore in $6 Billion Deal

Merck KGaA Revenues Up; Outlook Positive for 2010

Merck Sees Chemical, Pharma Acquisitions

Top-Feature

Capillary Electrophoresis in Biotherapeutic Development: Platform Methods, Fragment Workflows, and ADC Characterization

CHEManager International c/o Wiley-VCH GmbH

Upcoming Virtual Events

Predictive Simulation in Pharma Production

Evonik Industries AG

Safer, Scalable Pharmaceutical Manufacturing with Flow Chemistry

Article

The State of the US Specialty Chemicals Industry

Reshaping Specialty Chemicals Manufacturing

The State of the US Specialty Chemicals Industry

SOCMA's Jenn Klein examines how specialty chemical manufacturers — the invisible backbone behind pharmaceuticals, electronics, agriculture, and energy — are navigating supply chain shifts, policy uncertainty, and constant change while remaining resilient, disciplined, and focused on execution.